Study Stopped
Cooperation stooped with PI
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
1 other identifier
interventional
10
1 country
1
Brief Summary
In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also evaluate the effect of shallow fractional laser treatment versus deep parameters settings. If effective treatments could be performed at time of surgery, this would result in both time and cost saving to the patient and to the healthcare system and will improve patient's self-image post surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 4, 2013
CompletedFirst Posted
Study publicly available on registry
April 9, 2013
CompletedMarch 26, 2014
March 1, 2014
2 months
April 4, 2013
March 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scar appearance by blinded evaluation of photographs of the three month follow-up visit
three month follow-up
Study Arms (2)
Thin skin
EXPERIMENTALSingle fractional CO2 treatment at surgical area closure procedure on thin skin
Thick skin
EXPERIMENTALSingle fractional CO2 treatment at surgical area closure procedure on thick skin
Interventions
Eligibility Criteria
You may qualify if:
- Male or Females
- At least 18 and no more than 65 years old
- The surgical area closure in these subjects should be at least 4cm
- Type of surgery scheduled:
- Site 1: Surgical area closure on thin skin, including areas that require motion (e.g. face, hands, arms, thorax, etc.) Site 2: Surgical area closure on thick skin (abdominoplasty procedure)
- Willing to comply with study dosing and complete the entire course of the study
You may not qualify if:
- Active bacterial, fungal, or viral infection in the treatment area
- Active cold sores, or herpes in the treatment area
- Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study
- History of skin cancer, unless the surgical procedure of issue is for cancer treatment purposes.
- History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis)
- Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics)
- History or presenting with a keloid scar
- Any current or recent treatment for cancer, unless the surgical procedure of issue is for cancer treatment purposes.
- Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study
- Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
- Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator
- Female subject who is pregnant, nursing an infant or is less than 6 months after termination of breast feeding
- Small surgical closure (\<4cm)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lumenis Be Ltd.lead
Study Sites (1)
Ronald L. Moy, M.D.
Beverly Hills, California, 90210, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2013
First Posted
April 9, 2013
Study Start
January 1, 2013
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
March 26, 2014
Record last verified: 2014-03